Thomas W. Macallister

Biography

  Tom is a pharmaceutical executive with a PhD in molecular biology and over 25 years of experience including business development, drug discovery, preclinical and clinical development, regulatory strategy, intellectual property acquisition and enforcement, as well as commercialization. An expert in Phase 3 study design and implementation, Tom has previously assembled and led a team that took a program for severe traumatic brain injury from concept through completion of Phase 3 clinical trials. He has recently held the positions of CEO Argentum Pharmaceuticals, LLC; Chief Development Officer, Besins Healthcare SA; and President & CEO, BHR Pharma LLC. He is an attorney licensed to practice law in the Commonwealth of Virginia, the District of Columbia and before the United States Patent & Trademark Office. CLICK HERE TO EMAIL TOM  

Research Interest

 Molecular biology